Cargando…
Preparation and characterization of low-molecular-weight heparin/protamine nanoparticles (LMW-H/P NPs) as FGF-2 carrier
We produced low-molecular-weight heparin/protamine nanoparticles (LMW-H/P NPs) as a carrier for heparin-binding growth factors, such as fibroblast growth factor-2 (FGF-2). A mixture of low-molecular-weight heparin (MW: about 5000 Da, 6.4 mg/mL) and protamine (MW: about 3000 Da, 10 mg/mL) at a ratio...
Autores principales: | Mori, Yasutaka, Nakamura, Shingo, Kishimoto, Satoko, Kawakami, Mitsuyuki, Suzuki, Satoshi, Matsui, Takemi, Ishihara, Masayuki |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865009/ https://www.ncbi.nlm.nih.gov/pubmed/20463930 |
Ejemplares similares
-
Novel Experimental and Clinical Therapeutic Uses of Low-Molecular-Weight Heparin/Protamine Microparticles
por: Kishimoto, Satoko, et al.
Publicado: (2012) -
Biomedical Application of Low Molecular Weight Heparin/Protamine Nano/Micro Particles as Cell- and Growth Factor-Carriers and Coating Matrix
por: Ishihara, Masayuki, et al.
Publicado: (2015) -
Three-Dimensional Expansion Using Plasma-Medium Gel with Fragmin/Protamine Nanoparticles and FGF-2 to Stimulate Adipose-Derived Stromal Cells and Bone Marrow-Derived Mesenchymal Stem Cells
por: Kishimoto, Satoko, et al.
Publicado: (2012) -
Recent Progress on Heparin–Protamine Particles for Biomedical Application
por: Hata, Yuuki, et al.
Publicado: (2022) -
Protective effect of FGF-2 and low-molecular-weight heparin/protamine nanoparticles on radiation-induced healing-impaired wound repair in rats
por: Kinoda, Jun, et al.
Publicado: (2018)